In addition, the mutations of the RTKs family members anaplastic lymphoma kinase (ALK) and FGFR1 are reported to be associated with therapy-resistant relapses of the NB patients [48] and mutated ALK has been reported to contribute to the chemoresistance of NB [49, 50]. The gene discussed is ALK; the disease is neuroblastoma.